Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
Abstract Circulating tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). The CTC-endocrine therapy index (CTC-ETI), consisting of CTC-ER (estrogen receptor), BCL2, human epidermal growth factor receptor (HER2), and Ki67 expression, might predict resistance to endocrine therapy (ET) i...
Saved in:
Main Authors: | Costanza Paoletti, Meredith M. Regan, Samuel M. Niman, Emily M. Dolce, Elizabeth P. Darga, Minetta C. Liu, P. Kelly Marcom, Lowell L. Hart, John W. Smith, Karen L. Tedesco, Eitan Amir, Ian E. Krop, Angela M. DeMichele, Pamela J. Goodwin, Margaret Block, Kimberly Aung, Martha E. Brown, Robert T. McCormack, Daniel F. Hayes |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a4591a6d3a9d4069a97a9133183bb04c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
by: Elizabeth P Darga, et al.
Published: (2021) -
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer
by: Elizabeth P. Darga, et al.
Published: (2021) -
Neuroimmune endocrine effects of antidepressants
by: Antonioli M, et al.
Published: (2012) - Endocrine today
-
Endocrine research
Published: (1984)